Migraine and atrial fibrillation: a systematic review and meta-analysis
Camelia Qi En Lim,Yao Neng Teo,Tony Yi-Wei Li,Yao Hao Teo,Nicholas Li-Xun Syn,Aloysius Sheng-Ting Leow,Jamie Sin-Ying Ho,Toon Wei Lim,Swee-Chong Seow,Mark Yan Yee Chan,Raymond Ching Chiew Wong,Ping Chai,Amanda Chee Yun Chan,Vijay Kumar Sharma,Benjamin Yong-Qiang Tan,Leonard Leong Litt Yeo,Jonathan Jia Yuan Ong,Ching-Hui Sia
DOI: https://doi.org/10.4103/singaporemedj.smj-2022-114
2024-02-23
Singapore Medical Journal
Abstract:Abstract Background: Patients with migraines, particularly those with auras, may present with stroke. Atrial fibrillation is a known risk factor for stroke. With common pathophysiological factors between migraines and atrial fibrillation, we aimed to clarify the association between migraine and atrial fibrillation in this systematic review and meta-analysis. Methods: A literature search was conducted in EMBASE, PubMed, Scopus and Cochrane electronic bibliographic databases from inception to 5 September 2022 with the following inclusion criteria: (a) cohort or cross-sectional studies; (b) studies that included only patients aged ≥18 years; and (c) studies that examined the association between atrial fibrillation and migraines. Exclusion criteria were case–control studies and the studies that included patients with previous diagnosis of atrial fibrillation or nonmigrainous headache. The Newcastle–Ottawa Scale was used to assess the quality of studies. Results: Six studies were included, demonstrating a pooled prevalence of atrial fibrillation of 1.61% (95% confidence interval [CI] 0.51, 3.29) in migraine with aura and 1.32% (95% CI 0.17, 3.41) in migraine without aura. The overall prevalence of atrial fibrillation in migraine was 1.39% (95% CI 0.24, 3.46). Conclusion: In this systematic review and meta-analysis, the overall prevalence of atrial fibrillation in patients with migraine was low. Further studies are needed to clarify this relationship.
medicine, general & internal